Reduces oxidative stress and immune activation Promotes vascular repair in inflamed tissue May help maintain remission alongside standard therapies BPC-157 therapy in colitis models improved mucosal appearance, weight retention, and reduced systemic inflammation markers. Tkalcevic, V
Don't append it to an E/M code
For example, blood in the stool, persistent severe abdominal pain, unintended weight loss, fever, recurrent vomiting, or signs of dehydration should not be treated as routine wellness concerns
In pursuing cytoprotection research, a strong angiogenic effect of BPC 157 has been established, along with resolving external and internal wound healing [3,4,5,6,7,8,9,10,11,12,13,14,16,17,18,19,20,21,22,23,24,27,28,29,30,31,32,34,37,39,40]
GLP-1 receptor agonists (e.g., semaglutide, liraglutide): Revolutionized the treatment of type 2 diabetes and obesity